[Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it]

P Klener1

  • 11. interní hemato-onkologická klinika 1. LF a VFN a UHKT, Praha. pavel.klener@ruk.cuni.cz

Insights

Angiogenesis inhibitors target tumor growth and spread. This review classifies these agents by their mechanism, focusing on VEGF and other anti-angiogenic strategies for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Context:

  • Tumor growth, invasion, and metastasis are critically dependent on angiogenesis.
  • Significant advancements in developing angiogenesis inhibitors have occurred over the last decade.
  • Understanding the multifaceted nature of angiogenesis is key to developing effective cancer therapies.

Purpose:

  • To classify and review current angiogenesis inhibitors based on their targeted mechanisms within the angiogenic process.
  • To detail the role of Vascular Endothelial Growth Factor (VEGF) and its receptors in tumor angiogenesis.
  • To provide a comprehensive overview of diverse anti-angiogenic strategies.

Summary:

  • This review categorizes angiogenesis inhibitors according to their specific targets in the angiogenic cascade.
  • It elaborates on the significance of the VEGF pathway and its receptors.
  • Other strategies discussed include inhibiting endothelial cell proliferation, matrix metalloproteinases, and the use of vascular disrupting agents.

Impact:

  • Provides a structured classification of angiogenesis inhibitors for researchers and clinicians.
  • Highlights key molecular targets and pathways for anti-cancer drug development.
  • Offers insights into a range of therapeutic strategies beyond VEGF inhibition for combating cancer progression.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...